Endogenous cannabinoids: Metabolism and their role in reproduction

Life Sciences

Volumn 70, Issue 17, 2002, Pages 1963-1977

  Habayeb, Osama M H ^a   Bell, Stephen C ^a   Konje, Justin C ^a  

^a UNIVERSITY OF LEICESTER   (United Kingdom)

Author keywords

Anandamide; Fatty acid amide hydrolase; Lymphocytes Uterus

Indexed keywords

ANANDAMIDE; ARACHIDONIC ACID; CANNABINOID; CANNABINOID RECEPTOR; CYCLOOXYGENASE 2; ETHANOLAMINE; FATTY ACID AMIDASE; PROSTAGLANDIN E2;

ARACHIDONIC ACID METABOLISM; ARTICLE; CALCIUM TRANSPORT; EMBRYO DEVELOPMENT; FATTY ACID SYNTHESIS; HUMAN; MENSTRUAL CYCLE; NONHUMAN; PREGNANCY; REPRODUCTION; SEQUENCE HOMOLOGY; SPERMATOGENESIS; TISSUE DISTRIBUTION; UTERUS;

ANIMALS; ARACHIDONIC ACIDS; CANNABINOIDS; ENDOCANNABINOIDS; HUMANS; POLYUNSATURATED ALKAMIDES; RECEPTORS, CANNABINOID; RECEPTORS, DRUG; REPRODUCTION;

MAMMALIA;

EID: 0037087221     PISSN: 00243205     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0024-3205(01)01539-9     Document Type: Review

References (103)

1. Isolation and structure of a brain constituent that binds to the cannabinoid receptor
2. Identification of an endogenous 2-monoglyceride, present in canine gut, that binds to cannabinoid receptors
3. 2-Arachidonoylglycerol: A possible endogenous cannabinoid receptor ligand in brain
4. A second endogenous cannabinoid that modulates long-term potentiation
5. Two new unsaturated fatty acid ethanolamides in brain that bind to the cannabinoid receptor
6. Endocannabinoids: Endogenous cannabinoid receptor ligands with neuromodulatory actions
7. 2 dopamine receptors
8. The endogenous cannabinoid receptor agonist anandamide impairs memory in rats
9. 1 cannabinoid receptor antagonist SR141716A induces anxiety-like responses in the rat
10. 1 receptor antagonist SR141716A in rats as assessed by electroencephalographic spectral and sleep-waking cycle analysis
11. Changes in anandamide levels in mouse uterus are associated with uterine receptivity for embryo implantation
12. Maternal alcohol, tobacco and cannabis consumption and the outcome of pregnancy
13. Effects of maternal marijuana and cocaine use on fetal growth
14. Neonatal body proportionality and body consumption after in utero exposure to cocaine and marijuana
15. Substance misuse in pregnancy and relationship to fetal outcome
16. Marihuana smoking suppresses luteinizing hormone in women
17. Isolation and measurement of the endogenous cannabinoid receptor agonist, anandamide, in brain and peripheral tissues of human and rat
18. Biosynthesis and degradation of bioactive fatty acid amides in human breast cancer cells and rat pheochromocytoma cells-implications for cell proliferation and differentiation
19. Production and physiological actions of anandamide in the vasculature of the rat kidney
20. Liquid chromatographic-atmospheric pressure chemical ionization mass spectrometric determination of anandamide and its analogs in rat brain and peripheral tissues
21. 2+- dependent transacylase and phosphodiestrase activities
22. Isotope dilution GC/MS determination of anandamide and other fatty acylethanolamines in rat blood plasma
23. Occurrence and post mortem generation of anandamide and other long-chain N-acylethanolamines in mammalian brain
24. The endocannabinoid system as a target for therapeutic drugs
25. Formation and inactivation of endogenous cannabinoid anandamide in central neurons
26. Ontogenic development of the response to anandamide and delta 9-tatrahydrocannabinol in mice. Brain research
27. Metabolism of anandamide and 2- arachidonoylglycerol: A historic overview and some recent developments
28. Endocannabinoids and other fatty acid derivatives with cannabimimetic properties: Biochemistry and possible physiopathological relevance
29. Functional role of high-affinity anandamide transport as revealed by selective inhibition
30. Structural determinants for recognition and translocation by the anandamide transporter
31. Structure-activity relationships among N-arachidonylethanolamine (Anandamide) head group analogues for the anandamide transporter
32. Molecular characterization of an enzyme that degrades neuromodulatory fatty-acid amides
33. Molecular characterization of human and mouse fatty acid amide hydrolases
34. Conserved chromosomal location and genomic structure of human and mouse fatty-acid amide hydrolase genes and evaluation of clasper as a candidate neurological mutation
35. Enzymatic synthesis and degradation of anandamide, a cannabinoid receptor agonist
36. Inhibitors of arachidonoyl ethanolamide hydrolysis
37. Effects of anandamide on cannabinoid receptors in rat brain membranes
38. Evaluation of cannabinoid receptor binding and in vivo activities for cannabinoid analogs
39. An endogenous sleep-inducing compound is a novel competitive inhibitor of fatty acid amide hydrolase
40. Structure activity relationships of anandamide, an endogenous cannabinoid ligand
41. 2 ethanolamide from anandamide by cyclooxygenase-2
42. Lipooxygenase-catalyzed oxygenation of arachidonylethanolamide, a cannabinoid receptor agonist
43. Anandamide hydroxylation by brain lipooxygenase: Metabolite structures and potencies at the cannabinoid receptor
44. Human platelets and polymorphonuclear leukocytes synthesize oxygenated derivatives of arachidonylethanolamide (anandamide): Their affinities for the cannabinoid receptors and pathways of inactivation
45. Determination and characterization of a cannabinoid receptor in rat brain
46. Structure of a cannbinoid receptor and functional expression of the cloned cDNA
47. Molecular cloning of a human cannabinoid receptor which is also expressed in testis
48. Molecular characterization of a peripheral cannabinoid receptor
49. Identification of a functionally relevant cannabinoid receptor on mouse spleen cells that is involved in cannabinoid-mediated immune modulation
50. Cannabinoid-receptor expression in human leukocytes
51. Evidence for a cannabinoid receptor in sea urchin sperm and its role in blockade of the acrosome reaction
52. Anandamide (arachidonylethanolamide), a brain cannabinoid receptor agonist, inhibits fertilising capacity in sea urchin sperms by inhibiting the acrosome reaction
53. Cannabinoid-receptor signalling in the mouse uterus
54. Cannabinoid receptors and their role in the regulation of serotonin transporter in the human placenta
55. 1 cannabinoid receptors in human endothelial cells
56. 1 receptor mRNA in human vascular cells: Is 2-arachidonoylglycerol a possible vasomodulator
57. 1 receptors in the human anterior eye and retina
58. 1 cannabinoid receptors mRNA and protein
59. Cannabinoid inhibition of adenylate cyclase-mediated signal transduction and interleukin 2 (IL-2) expression in the murine T-cell line, EL4.IL-2
60. Attenuation of inducible nitric oxide synthase gene expression by delta 9-tetrahydrocannabinol is mediated through the inhibition of nuclear factor kappa B/Rel activation
61. Mast cells express a peripheral cannabinoid receptor with differential sensitivity to anandamide and palmitoylethanolamide
62. Cannabinoid inhibition of adenylate cyclase. Biochemistry of the response in neuroblastoma cell membranes
63. i in the inhibition of adenylate cyclase by cannabimimetic drugs
64. Cannabinoid receptors and modulation of cyclic AMP accumulation in the rat brain
65. Solubiliziation of the cannabinoid receptor from rat brain and its functional interaction with guanine nucleotide-binding proteins
66. Pharmacology of cannabinoid receptors
67. Cannabinoids inhibit N-type calcium channels in neuroblastomaglioma cells
68. Cannabinoid receptor agonists inhibit calcium currents in NG 108-15 neuroblastoma cells via a pertussis toxin-sensitive mechanism
69. Endocannabinoids
70. Dual effects of anandamide on NMDA receptor-mediated responses and neurotransmission
71. 2+ channel
72. Arachidonylethanolamide (anandamide) binds with low affinity to dihydropyridine binding sites in brain membranes
73. Delta 9-tetrahydrocannabinol: A potent inhibitor of episodic luteinizing hormone secretion
74. Delayed sexual maturation in the female rat during exposure to delta 9-tetrahydrocannabinol
75. 1-terahydrocannabinol
76. Acute effect of delta 1-tetrahydrocannabinol on the hypothalamic-pituitary-ovarian axis in the rat
77. The effect of prepubertal administration of marihuana (delta 9-tetrahydrocannabinol) on the onset of puberty and the postpubertal reproductive functions in female rats
78. Effects of daily administration of tetrahydrocannabinol on rat preovulatory follicles. A quantitative electron-microscopic analysis
79. Effect of tetrahydrocannabinol on the hypothalamic-pituitary axis in the ovariectomized rhesus monkey
80. The effects of cannabinoids on the regulation of reproduction
81. 1 receptor mRNA in the pituitary gland
82. 1 cannabinoid receptors in the anterior lobe of the pituitary gland
83. 1 receptors in hypothalamic structures and their involvement in the effects of cannabimimetics
84. 1 receptor mRNA and endocannabinoid levels in the anterior pituitary gland
85. Effects of anandamide on gestation in pregnant rats
86. The effects of prenatally administered endogenous cannabinoids on rat offspring
87. Quantitative evaluation of spermatogenesis in mice following chronic exposure to cannabinoids
88. Depression of plasma testosterone levels after chronic intensive marihuana use
89. Marihuana-induced embryotoxicity in the rabbit
90. Blastocyst's state of activity determines the "window" of implantation in the receptive mouse uterus
91. The uterus is a potential site for anandamide synthesis and hydrolysis: Differential profiles of anandamide synthase and hydrolase activities in the mouse uterus during the periimplantation period
92. Fatty-acid amide hydrolase is expressed in the mouse uterus during the periimplantation period
93. Down-regulation of anandamide hydrolase in mouse uterus by sex hormones
94. The preimplantation mouse embryo is a target for cannabinoid ligand-receptor signalling
95. Activation of brain-type cannabinoid receptors interferes with preimplantation mouse embryo development
96. Effects of cannabinoids on preimplantation mouse embryo development and implantation are mediated by brain-type cannabinoid receptors
97. Ligand-receptor signalling with endocannabinoids in preimplantation embryo development and implantation
98. Stage-specific excitation of cannabinoid receptor exhibits differential effects on mouse embryonic development
99. Dyregulated cannabinoid signalling disrupts uterine receptivity for embryo implantation
100. Relation between decreased anandamide hydrolase concentrations in human lymphocytes and miscarriage
101. Progesterone up-regulates anandamide hydrolase in human lymphocytes: Role of cytokines and implications for fertility
102. Defective production of both leukaemia inhibitory factor and type 2 T-helper cytokines by decidual T cells in unexplained recurrent abortions
103. Prediction of pregnancy loss